Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
209 Leser
Artikel bewerten:
(0)

Harvest Technologies Corporation Files Patent Infringement Complaint against ThermoGenesis Corporation

PLYMOUTH, Mass., Oct. 24, 2012 /PRNewswire/ -- Harvest Technologies Corporation (Harvest) announced that it filed a patent infringement complaint on October 24, 2012 in the US District Court of Delaware against ThermoGenesis Corporation (ThermoGenesis). The complaint alleges that ThermoGenesis' Res-Q' 60 BMC system (*also known as ART 21®) infringes two patents for which Harvest Technology owns the rights. These patents relate to Harvest's proprietary floating shelf technology that has been shown in studies to provide superior cellular concentration. The complaint also requests an injunction against further sales of the product in the U.S.

"Harvest Technologies respects the valid intellectual property of others and expects that its competitors will do the same. Harvest has invested millions of dollars in development of its cellular therapy products for many years and cannot allow others to profit by our innovations," said Gary Tureski, President and CEO, Harvest Technologies Corporation.

Harvest Technologies is the leading Cellular Therapy global manufacturer that has developed point-of-care products to process and concentrate multiple biologics. These include high-density platelet rich plasma (APC+®), bone marrow aspirate concentrate (BMAC®) and adipose tissue. The company is headquartered in Plymouth, Massachusetts. It is one of several subsidiaries of Terumo Corporation of Japan that is focused in cellular therapies and biologics. For more information, visit www.harvesttech.com or call 508-732-7500.

Tokyo-based Terumo Corporation is one of the world's leading medical device manufacturers with $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures, and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures, and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use.

Harvest is a registered trademark of Harvest Technologies Corporation. Terumo® is a registered trademark of Terumo Corporation. Res-Q is a trademark of ThermoGenesis Corporation.

*ART 21 is a trademark of Celling Technologies®

SOURCE Harvest Technologies Corporation

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.